Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaser Atlasi

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Cancers|July 24, 2021
Deregulation of Transcriptional Enhancers in CancerFatemeh Mirzadeh Azad, Yaser Atlasi
Trends in Cell Biology|March 29, 2021
WNT-Regulated Transcriptional Enhancers and Stem Cell PlasticityFatemeh Mirzadeh Azad, Yaser Atlasi
Nature Cell Biology|April 18, 2018
Brd4-independence in ground state pluripotencyYaser Atlasi, Hendrik G Stunnenberg
Nature Reviews. Genetics|August 15, 2017
The interplay of epigenetic marks during stem cell differentiation and developmentYaser Atlasi, Hendrik G Stunnenberg
Current Topics in Developmental Biology|January 21, 2014
Cancer stem cells, pluripotency, and cellular heterogeneity: a WNTer perspectiveYaser Atlasi, Leendert Looijenga, Riccardo Fodde
Stem Cells (Dayton, Ohio)|April 10, 2024
The epigenetic landscape in intestinal stem cells and its deregulation in colorectal cancerAxelle E M Larue, Yaser Atlasi
Science (New York, N.Y.)|February 7, 2015
Developmental biology. A Me6Age for pluripotencyHendrik G Stunnenberg, Michiel Vermeulen, Yaser Atlasi
The FEBS Journal|October 25, 2022
Functional role of lncRNAs in gastrointestinal malignancies: the peculiar case of small nucleolar RNA host gene familyMorvarid Saeinasab, Yaser Atlasi, Maryam M Matin
Cancer Detection and Prevention|February 3, 2009
Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancerYaser Atlasi, Seyed Javad Mowla, Seyed Amir-Mohsen Ziaee
International Journal of Cancer|January 6, 2007
OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancerYaser Atlasi, Seyed J Mowla, Seyed A M Ziaee, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Cancers|July 24, 2021
Deregulation of Transcriptional Enhancers in CancerFatemeh Mirzadeh Azad, Yaser Atlasi
Trends in Cell Biology|March 29, 2021
WNT-Regulated Transcriptional Enhancers and Stem Cell PlasticityFatemeh Mirzadeh Azad, Yaser Atlasi
Nature Cell Biology|April 18, 2018
Brd4-independence in ground state pluripotencyYaser Atlasi, Hendrik G Stunnenberg
Nature Reviews. Genetics|August 15, 2017
The interplay of epigenetic marks during stem cell differentiation and developmentYaser Atlasi, Hendrik G Stunnenberg
Current Topics in Developmental Biology|January 21, 2014
Cancer stem cells, pluripotency, and cellular heterogeneity: a WNTer perspectiveYaser Atlasi, Leendert Looijenga, Riccardo Fodde
Stem Cells (Dayton, Ohio)|April 10, 2024
The epigenetic landscape in intestinal stem cells and its deregulation in colorectal cancerAxelle E M Larue, Yaser Atlasi
Science (New York, N.Y.)|February 7, 2015
Developmental biology. A Me6Age for pluripotencyHendrik G Stunnenberg, Michiel Vermeulen, Yaser Atlasi
The FEBS Journal|October 25, 2022
Functional role of lncRNAs in gastrointestinal malignancies: the peculiar case of small nucleolar RNA host gene familyMorvarid Saeinasab, Yaser Atlasi, Maryam M Matin
Cancer Detection and Prevention|February 3, 2009
Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancerYaser Atlasi, Seyed Javad Mowla, Seyed Amir-Mohsen Ziaee
International Journal of Cancer|January 6, 2007
OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancerYaser Atlasi, Seyed J Mowla, Seyed A M Ziaee, et al.
Pageof 4